newsfilter
← Latest News
GlobeNewswire·

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

‒ Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm ‒ ‒ Company Announces Acquisition of Melinta Therapeutics ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒